Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study

Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study

Abstract Background The aim of this study was to explore the characteristics and prognostic information of estrogen receptor-positive/progesterone receptor-negative (ER+/PR−) male breast cancer. Methods Using the US National Cancer Institute’s Surveillance, Epidemiology, and End Results database, we...

Full description

Bibliographic Details
Main Authors:	Jin-Li Wei, Jia-Xin Zhang, De-Yuan Fu
Format:	Article
Language:	English
Published:	BMC 2018-12-01
Series:	World Journal of Surgical Oncology
Subjects:	Male breast cancer Progesterone receptor Estrogen receptor Cancer-specific survival Overall survival
Online Access:	http://link.springer.com/article/10.1186/s12957-018-1539-7

Similar Items

Estrogen and progesterone receptor expression in breast carcinoma
by: TB Pathak, et al.
Published: (2011-10-01)

Prognostic Impact of Low Estrogen and Progesterone Positivity in Luminal B (HER2 Negative) Breast Cancer
by: Jasmina Rajc, et al.
Published: (2018-01-01)

Evaluating Association of Tissue Selenium Level and Estrogen Receptor and Progesterone Receptor Expression in Breast Cancer
by: Sanaz Salar Amoli, et al.
Published: (2019-03-01)

Correlation of interleukin 6 (IL-6) with estrogen and progesterone receptor expression in breast cancer patients
by: Amal K. Chaloob
Published: (2011-01-01)

Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models
by: Rayna Rosati, et al.
Published: (2020-06-01)

Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome than Those with Lower Levels of Tumor Progesterone Receptor
by: Tai-Han Lin, et al.
Published: (2021-02-01)

Study of Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor Expression by Immunohistochemistry in Breast Carcinoma
by: Saroj Deoghare, et al.
Published: (2018-01-01)

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
by: Lower EE, et al.
Published: (2017-08-01)

Estrogen Receptor Positive/Progesterone Receptor Negative Breast Carcinomas: A Subgroup Deserves Particular Interest
by: Zühal GÜCİN, et al.
Published: (2015-08-01)

Concordant Expression of Estrogen and Progesterone Receptors in Primary and Loco-regional Recurrent Breast Cancer
by: Sedigheh Tahmasebi, et al.
Published: (2013-07-01)

Sodium iodide symporter, estrogen receptor, and progesterone receptor expression in carcinoma breast - An immunohistochemical analysis
by: Ashwani Tandon, et al.
Published: (2011-01-01)

Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01)

Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer
by: Susanne Schüler-Toprak, et al.
Published: (2018-10-01)

Profiling estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2/neu in breast carcinoma: Study of 111 consecutive cases
by: Muninder Negi, et al.
Published: (2018-01-01)

Interaction of Estrogen and Progesterone Receptors, and Human Epithelial Receptor 2, with Breast cancer Risk factors: a Multi-center case-only study in Iran
by: Rahim Akrami, et al.
Published: (2016-08-01)

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells
by: Gaetano Verde, et al.
Published: (2018-10-01)

The Role of Estrogen in the Development of Breast Cancer
by: Nikki Aldi Massardi
Published: (2021-03-01)

Estrogen and progesterone receptor testing in breast carcinoma: concordance of results between local and reference laboratories in Brazil
by: Sheila Cristina Lordelo Wludarski, et al.

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?
by: O. O. Gordeeva, et al.
Published: (2019-04-01)

Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
by: Zhao X, et al.
Published: (2021-06-01)

Expression of estrogen and progesterone receptors in subcutaneous endometriosis
by: Đorđević M., et al.
Published: (2010-01-01)

Comparison of Estrogen Receptor and Progesterone Receptor in Ductal Carcinoma and Lobular Carcinoma With Regard to Age Prevalence
by: Seyed Morteza Mousavi Naeini, et al.
Published: (2017-08-01)

Differences in the expression of 4 progesterone receptor antibodies EP2, SP2, 1E2, and 16 in non-specific invasive breast cancers
by: LI Sanyan, et al.
Published: (2020-05-01)

Immunohistochemical evaluation of estrogen and progesterone receptors in peripheral and central giant cell granuloma of the jaws
by: Razavi SM, et al.
Published: (2006-07-01)

Clinical and estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status correlation study in breast cancer patients: An experience from a tertiary care center
by: Rashmi Singh, et al.
Published: (2020-01-01)

Expression of estrogen and progesterone receptors in astrocytomas: a literature review
by: Cléciton Braga Tavares, et al.

Physiological factors affecting ovine uterine estrogen and progesterone receptor concentrations
by: Prater, Patrice L.
Published: (2013)

Correlation of estrogen and progesterone receptors ER and PR expression with the growth of endometrial cancer
by: Xiang-Zhuan Gao, et al.
Published: (2017-07-01)

The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status
by: Hengqiang Zhao, et al.
Published: (2021-05-01)

Effects of HER2 status on the prognosis of male breast cancer: a population-based study
by: Chen L, et al.
Published: (2019-09-01)

Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
by: Crystal C. Lipsey, et al.
Published: (2020-05-01)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
by: Lenhard Miriam, et al.
Published: (2012-11-01)

Influence of Androgen Receptor on the Prognosis of Breast Cancer
by: Ki-Tae Hwang, et al.
Published: (2020-04-01)

Levels of estrogen receptor B splice variant (ERBΔ5) mRNA correlates with progesterone receptor in breast carcinomas
by: Mandušić Vesna, et al.
Published: (2010-01-01)

Immunocytochemical evaluation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 in breast cancer cell blocks and corresponding tissue blocks: A single institutional experience
by: Nasar Yousuf Alwahaibi, et al.
Published: (2018-01-01)

Distribution of estrogen and progesterone receptors in the primate ovary, with emphasis on subpopulations of cells within the corpus luteum.
by: Hild-Petito, Sheri Ann.
Published: (1988)

Estrogen and progesterone receptors in human papilloma virus-related cervical neoplasia
by: F.R.G. Coelho, et al.
Published: (2004-01-01)

The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells
by: Marina Mihaela, et al.
Published: (2012-07-01)

Immunohistochemical research of estrogen and progesterone receptors in the foci of retrocervical endometriosis
by: I. Yu. Oliynyk
Published: (2012-12-01)

Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population
by: María Sol Recouvreux, et al.
Published: (2020-09-01)